QA: Pacira BioSciences Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001396814_2022_Pacira_BioSciences_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 4331.264, 'aggregate_val': 541533000, 'exp_sum': 125000, 'exp_to_value': {'remainder_Revenues': 125000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001396814, Pacira BioSciences Inc.

  xvar xval
0 AssetsCurrent 866,048,000
1 IntangibleAssetsNetIncludingGoodwill 769,143,000
2 PropertyPlantAndEquipmentNet 188,401,000
3 remainder_Assets 251,761,000
4 LiabilitiesCurrent 521,118,000
5 LiabilitiesNoncurrent 91,699,000
6 remainder_Liabilities 732,128,000
7 CostOfGoodsAndServicesSold 140,255,000
8 SellingGeneralAndAdministrativeExpense 199,345,000
9 ResearchAndDevelopmentExpense 55,545,000
10 remainder_Expenses 70,888,000
11 remainder_Revenues 541,533,000
12 remainder_NetIncome -33,520,000
13 remainder_ComprehensiveNetIncome -151,000
  yvar yval
0 Assets 2,075,353,000
1 Liabilities 1,344,945,000
2 Expenses 466,033,000
3 Revenues 541,533,000
4 StockholdersEquity 730,408,000
5 NetIncome 41,980,000
6 ComprehensiveNetIncome 41,904,500
7 BaseVar 2,230,767,500
8 EconomicCapitalRatio 0.759

Edgar->Model Mapping

Feature Distribution

Change over Time